Mutations in Filamin C Associated with Both Alleles Do Not Affect the Functioning of Mice Cardiac Muscles

Filamin C (FLNC) is a structural protein of muscle fibers. Mutations in the FLNC gene are known to cause myopathies and cardiomyopathies in humans. Here we report the generation by a CRISPR/Cas9 editing system injected into zygote pronuclei of two mouse strains carrying filamin C mutations—one of them (AGA) has a deletion of three nucleotides at position c.7418_7420, causing E>>D substitution and N deletion at positions 2472 and 2473, respectively. The other strain carries a deletion of GA nucleotides at position c.7419_7420, leading to a frameshift and a premature stop codon. Homozygous animals (FlncAGA/AGA and FlncGA/GA) were embryonically lethal. We determined that FlncGA/GA embryos died prior to the E12.5 stage and illustrated delayed development after the E9.5 stage. We performed histological analysis of heart tissue and skeletal muscles of heterozygous strains carrying mutations in different combinations (FlncGA/wt, FlncAGA/wt, and FlncGA/AGA). By performing physiological tests (grip strength and endurance tests), we have shown that heterozygous animals of both strains (FlncGA/wt, FlncAGA/wt) are functionally indistinguishable from wild-type animals. Interestingly, compound heterozygous mice (FlncGA/AGA) are viable, develop normally, reach puberty and it was verified by ECG and Eco-CG that their cardiac muscle is functionally normal. Intriguingly, FlncGA/AGA mice demonstrated better results in the grip strength physiological test in comparison to WT animals. We also propose a structural model that explains the complementary interaction of two mutant variants of filamin C. © 2025 by the authors.

Авторы
Ilchuk L.A. , Kochegarova K.K. , Baikova I.P. , Safonova P.D. , Bruter A.V. , Kubekina M.V. , Okulova Y.D. , Minkovskaya T.E. , Kuznetsova N.A. , Dolmatova D.M. , Ryabinina A.Y. , Mozhaev A.A. , Belousov V.V. , Ershov B.P. , Timashev P.S. , Filatov M.A. , Silaeva Y.Y.
Издательство
MDPI AG
Номер выпуска
4
Язык
Английский
Статус
Опубликовано
Номер
1409
Том
26
Год
2025
Организации
  • 1 Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russian Federation
  • 2 Core Facility Center, Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russian Federation
  • 3 Institute for Regenerative Medicine, Sechenov University, Moscow, 119991, Russian Federation
  • 4 Laboratory of Molecular Oncobiology, Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russian Federation
  • 5 V.A. Frolov Department of General Pathology and Pathological Physiology, Institute of Medicine, Peoples’ Friendship, University of Russia, RUDN University), 6 Miklukho-Maklaya Street, Moscow, 117198, Russian Federation
  • 6 Laboratory of Molecular Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russian Federation
  • 7 Group of Genome Editing Techniques, Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, 117513, Russian Federation
  • 8 Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, 117513, Russian Federation
  • 9 Chemistry Department, Lomonosov Moscow State University, Moscow, 119991, Russian Federation
Ключевые слова
animal model; cardiomyopathy; filamin C; flnc
Цитировать
Поделиться

Другие записи